MT 200605
Alternative Names: MT-200605Latest Information Update: 20 Jul 2023
At a glance
- Originator Shaanxi Micot Technology Co
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I CNS disorders
Most Recent Events
- 11 Jul 2023 Phase-I clinical trials in CNS disorders (In volunteers) in China (IV) (NCT05948774)
- 08 Sep 2020 Early research in CNS disorders in China (Unspecified) (Shaanxi Micot Technology pipeline September 2020)